Nisa Investment Advisors
CNST

Nisa Investment Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Nisa Investment Advisors’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-410
Closed -$14 – 2372
2021
Q2 		$14 Hold
410
– – ﹤0.01% 2186
2021
Q1 		$10 Hold
410
– – ﹤0.01% 2212
2020
Q4 		$12K Buy
410
+50
+14% +$1.26K ﹤0.01% 2199
2020
Q3 		$7K Hold
360
– – ﹤0.01% 2171
2020
Q2 		$11K Buy
+360
New +$13K ﹤0.01% 1911
2020
Q1 		– Sell
-5,900
Closed -$278K – 2163
2019
Q4 		$278K Buy
+5,900
New +$170K ﹤0.01% 1255

Nisa Investment Advisors's CNST Position: Q3 2021 in Review

Nisa Investment Advisors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 410 shares — an estimated $14 sold.

Nisa Investment Advisors first reported a position in CNST in Q4 2019 and held it in 6 quarters. The position peaked at $278K in Q4 2019. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Nisa Investment Advisors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 410 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $14.
  • Nisa Investment Advisors first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 6 quarters.
  • Nisa Investment Advisors's Constellation Pharmaceuticals, Inc. position peaked at $278K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Nisa Investment Advisors's 13F filing for Q3 2021, filed 18 Oct 2021.